Search Results for 'sanofi'
Contract Service Directory Companies
View All Buyers Guide Companies »
-
-
Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
SRI, Sanofi Enter Drug Discovery Collaboration
Will leverage SynFini, SRI’s artificial intelligence and automation platform to accelerate development of small-molecule drug targets.07.07.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Sanofi Launches Dedicated mRNA Vaccines CoE
Approximately €400million investment annually aims to accelerate end-to-end R&D of next-generation vaccines.06.30.21
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Sanofi Invests $425M in Flu Vaccine Manufacturing Facility
Newly licensed U.S. manufacturing facility to increase availability of Fluzone High-Dose Quadrivalent.06.17.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News
Sanofi, Moderna Enter COVID-19 Vaccine Fill/Finish Manufacturing Deal
Sanofi will provide fill/finish services for up to 200 million doses of Moderna’s COVID-19 vaccine in the U.S. beginning in September 2021.Tim Wright, Editor, Contract Pharma 05.03.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Sanofi Invests in Cutting Edge Vax Production Site in Singapore
The factory will house several fully digitalized modules that allow production of three to four vaccines simultaneously.Kristin Brooks 04.12.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Sanofi Acquires Tidal Therapeutics
Gains novel mRNA-based technology with research capabilities in immuno-oncology and inflammatory diseases, with potential in other disease areas.Kristin Brooks 04.12.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Parenterals
Sanofi to Build New $700M Flu Vaccine Facility in Canada
Facility will be located in Toronto and will increase supply of influenza vaccines in Canada, the U.S. and Europe.Tim Wright, Editor, Contract Pharma 04.05.21
-
APIs | Breaking News | Facilities | Industry News
Sanofi Unveils EUROAPI as Name of New European API Company
Appoints Karl Rotthier as its future Chief Executive Officer.Contract Pharma Staff 01.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Sanofi to Acquire Kiadis for $359M
Adds next-gen natural killer cell platform and pipeline of cell-based cancer immune-therapeutics and infectious disease therapies.Contract Pharma Staff 11.03.20
-
Breaking News | Industry News
Sanofi to Acquire Principia Biopharma in $3.6B Deal
Principia's Bruton tyrosine kinase inhibitors add to Sanofi's efforts to accelerate a portfolio of next-gen treatments for autoimmune diseases.Contract Pharma Staff 08.17.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Sanofi and GSK Selected for Operation Warp Speed
To supply U.S. government with 100 million doses of COVID-19 vaccine in $2.1 billion deal.Contract Pharma Staff 08.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Sanofi and GSK Strike COVID-19 Vax Deal with UK Govt.
Will supply up to 60 million doses of the vaccine if approved, Phase 1/2 study expected to start in September.Contract Pharma Staff 07.29.20
-
-
Breaking News | Collaborations & Alliances | Drug Development
Kymera, Sanofi Enter Multi-program Strategic Alliance
To develop and commercialize first-in-class protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases.Contract Pharma Staff 07.09.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Sanofi and Translate Bio Expand Vaccine Collaboration
To develop mRNA vaccines across all infectious disease areas in a deal potentially worth up to $1.9 billion.Contract Pharma Staff 06.26.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Sanofi Invests $679M in Two French Vaccine Sites
Will create a state-of-the-art vaccine production site and a new research center dedicated to vaccinesContract Pharma Staff 06.16.20
-
Breaking News | Injectables | Packaging & Tracking
Schreiner MediPharm Supplies Booklet-Label for Sanofi Trial
Specialty Label for Needle Protection System comprises more than 30 pages, in more than 20 languages.Contract Pharma Staff 05.07.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
Regeneron, Sanofi Release Preliminary Phase II Kevzara Results in COVID-19
Kevzara rapidly lowered C-reactive protein (CRP), a key marker of inflammation, meeting the primary endpoint.Contract Pharma Staff 04.27.20
-
Breaking News | Industry News
FDA’s CTAP to Expedite COVID-19 Countermeasures
New program across public, academic and private sectors aims to expedite the development of life-saving treatmentsContract Pharma Staff 04.07.20
-
Breaking News | Industry News | Promotions & Moves
I-Mab Makes Executive Appointment
Names Gigi Feng as vice president and global head of corporate communications03.24.20
-
Sanofi, Regeneron in COVID-19 Pact
Begin global Kevzara (sarilumab) clinical trial program in patients with severe COVID-1903.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development
COVID-19 Clinical Trials
The vaccines in development for COVID-19, who's developing them, and where they stand in the development processOnline Exclusives Kristin Brooks, Contract Pharma 03.10.20
-
Chemistry
Greener by Design
How new approaches to green chemistry are driving sustainable processes.Kenneth Ball, Commercial Operations Lead, Pfizer CentreOne 03.04.20
-
APIs | Breaking News | Industry News
Sanofi Creates New API Company in Europe
Will be world’s second largest API maker with €1 billion in sales by 202202.28.20
-
Breaking News | Industry News | Promotions & Moves
Vectura Expands Executive Leadership Team
Appoints Sharon Johnson as executive vice president for delivery management02.10.20
-
Breaking News | Promotions & Moves
Eisai Expands Leadership Team
Adds two key appointments in the areas of Corporate Affairs and Market Access02.03.20
-
Bio News | Breaking News | Facilities | Industry News
VIDEO: Boyd Releases “Global Biomanufacturing Costs” Report
John Boyd discusses details from his firm's new biomanufacturing site selection costs report.01.24.20
-
Boyd Releases “Global Biomanufacturing Costs” Report
John Boyd discusses details from his firm's new biomanufacturing site selection costs report.Videos
-
Breaking News | Collaborations & Alliances | Drug Development
Evotec Achieves Third Sanofi Milestone
Meets pre-agreed critical criteria within the beta cell replacement therapy program under diabetes research alliance12.20.19
-
Breaking News | Industry News
Evotec, Sanofi Expand Services Agreement
Sanofi will transfer its liquid compounds to Evotec in Toulouse, combining central storage and sample delivery12.19.19
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
U.S.-based, state-of-the-art facilities to be established for sustainable production of adjuvanted recombinant vaccine for use in the event of a pandemic.Sanofi 12.13.19
-
Breaking News | Drug Development | Industry News
Sanofi Acquires Synthorx in $2.5B Deal
CA-based immuno-oncology company expands Sanofi's cancer and autoimmune pipeline12.10.19
-
Breaking News | Drug Development | Promotions & Moves
Locana Appoints CEO
James Burns is an accomplished company builder and biopharmaceutical product developer12.10.19
-
Breaking News | Collaborations & Alliances | Drug Development
Regeneron, Sanofi Amend Antibody Alliance
Sanofi to gain global rights to Kevzara and sole ex-U.S. rights to Praluent, Regeneron to gain sole U.S. rights to Praluent12.10.19
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Sanofi Pasteur Awarded HHS Pandemic Flu Vax Contract
To increase domestic pandemic influenza vaccine production capabilities in Swiftwater, PA12.09.19
-
Logistics | Serialization | Supply Chain
Sanofi Genzyme on Trends in Pharma Supply Chains
Jim Calarese of Sanofi Genzyme discusses how merging two companies can prove even more difficult when their supply chains are highly dissimilarVideos
-
Biologics, Proteins, Vaccines | Facilities
Sanofi Ushers in Next-Gen Biotech Manufacturing
Opens its first digitally-enabled continuous manufacturing facility.Slideshows10.18.19
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Information Technology
Sanofi Ushers in Next-Gen Biotech Manufacturing
Opens its first digitally-enabled continuous manufacturing facility10.15.19
-
Cytotoxics and High Potency Manufacturing
-
Promotions & Moves
CANbridge Appoints SVP, Rare Disease Commercial Operations
Marcelo Cheresky brings nearly 20 years' business leadership experience in the biotechnology industry07.30.19
-
cGMP Manufacture | Industry News
Opiant Pharmaceuticals, Sanofi to Manufacture Acute Cannabinoid Overdose Treatment
Opiant’s drinabant, selective cannabinoid receptor antagonist, could be first approved treatment for ACO07.24.19
-
Top 25 Pharma and Biopharma Companies
(Based on 2018 Pharma/Biopharma Sales, in $U.S. Millions)Tim Wright & Kristin Brooks 07.18.19
-
-
-
The Top Companies Report
Combined sales for 2018 topped the $600 billion markTim Wright, Editor 07.15.19
-
cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Catalent Expands Global Spray Drying Ops
Agreement with Sanofi Active Ingredient Solutions provides access to spray drying manufacturing services at Sanofi’s Haverhill, UK facility07.09.19
-
Industry News | R&D
Sanofi Restructures R&D Group
To eliminate 466 jobs in France and Germany as part of a reorganization to focus on its immuno-oncology pipeline and gene therapies06.21.19
-
Drug Development | Drug Discovery | Industry News | Laboratory Testing
Sanofi and Google to Develop Innovation Lab
Virtual healthcare Innovation Lab aims to radically transform how future medicines and health services are delivered06.18.19
-
Collaborations & Alliances | Drug Development
Voyager Therapeutics, Sanofi Genzyme Restructure Gene Therapy Alliance
Voyager gains worldwide rights to VY-HTT01 Huntington’s disease program and ex-U.S. rights to VY-FXN01 Friedreich’s ataxia program for $10 million upfront06.17.19
